Working together to reduce the global burden of kidney cancer

Kidney cancer is a global issue. Every year, 338,000 people worldwide will be diagnosed with kidney cancer.

Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.

World Kidney Cancer Q&A Day

The second World Kidney Cancer Q&A Day was a great success.

We are building momentum worldwide, in our first two years we have achieved:

650,000 social media impressions
Over 20,000 people have completed the World Kidney Cancer Q&A Day Quiz.

Global Patient Survey

Together with 25 patient organisations around the world, the IKCC is conducting the first-ever global patient and caregiver survey to better understand the patient experience with kidney cancer. We welcome you to complete the survey in the language of your choice.

Updates from IKCC

IKCC Kidney Cancer @IKCCorg

3 hours ago
Meeting up with international #kidneycancer advocates at ESMO. Thanks for helping with our booth between face-paced sessions! #flatshoes #survival https://t.co/s3f57QvZe3

View on Twitter

2

IKCC Kidney Cancer Retweeted · Daniel Heng @DrDanielHeng

7 hours ago
Atez Bev improves PFS in transcriptome angiogenesis low and t effector high subgroups in #mRCC. Makes sense. Great biomarker work and look forward to updates in PFS and OS for this combination in #kidneycancer @Uromigos #ESMO18 https://t.co/agyg1A0GnT

View on Twitter

7

IKCC Kidney Cancer Retweeted · Sumanta Pal @montypal

12 hours ago
Great overview of #kidneycancer tx at #ESMO18 by @marco_g__ - very comprehensive. Alongside @DrChoueiri’s SAVOIR study for PRCC which is also enrolling in Europe, we have a study in US & Canada comparing Sunitinib to 3 MET inhibitors, @SWOG 1500. https://t.co/zOj2efGESr

View on Twitter

11

Did you know?

Kidney cancer is often found by accident.

Kidney cancer is the 12th most prevalent cancer worldwide.

About 59 per cent of kidney cancer cases occur in more developed countries.

Our Global Network

IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.

Explore Our Global Network